Moderator: Jong Wook KIM (Korea)
Time | Program | Chair / Speaker |
---|---|---|
12:00-13:00 | Lunch | |
13:00-13:20 | Welcome Remarks | Jae-Young JOUNG (Korea) (President, KPS) |
Ji Youl LEE (Korea) (President, APSU) |
||
Seong Il SEO (Korea) (President, KUA) |
||
13:20-14:50 | Session I: Prostate Cancer I (Screening & Biopsy): Changing Paradigms | Seong Il SEO (Korea) |
Seok Joong YUN (Korea) | ||
Takashi FUKAGAI (Japan) | ||
13:20-13:30 | National health strategies to the sharp rise in prostate cancer incidence | Young Hwii KO (Korea) |
13:30-13:37 | What is the optimal approach to prostate cancer screening? MRI first or PSA first | Won Hoon SONG (Korea) |
13:37-13:57 | Rethinking Prostate Biopsy in the PSA Screening Era: Toward Precision and Individualization | Ilker TINAY (Türkiye) |
13:57-14:04 | Local anaesthetic transperineal biopsy versus transrectal prostate biopsy in prostate cancer detection | Dongho SHIN (Korea) |
14:04-14:11 | Role of lesional and perilesional sampling in patients undergoing prostate biopsies : are standard biopsies necessary? | Sang Wook LEE (Korea) |
14:11-14:50 | Panel Discussion | Tae Hyo KIM (Korea) |
Jong Hyun YOON (Korea) | ||
Won Tae KIM (Korea) | ||
Jae Heon KIM (Korea) | ||
Bannakij LOJANAPIWAT (Thailand) | ||
14:50-15:30 | Satellite Symposium sponsored by Novartis | Ji Youl LEE (Korea) |
14:50-15:10 | From VISION to Real-World: Practical Insights on Implementing PSMA Radioligand Therapy | Frédéric POULIOT (Canada) |
15:10-15:30 | Coffee Break / Visit Exhibits | |
15:30-17:30 | Session II: Prostate Cancer II (Locally advanced disease): Navigating Treatment Strategies | Sung Kyu HONG (Korea) |
Jun Sung KOH (Korea) | ||
Takahiro KIMURA (Japan) | ||
15:30-15:50 | The comparison of outcomes between neoadjuvant novel and classic hormonal therapy in patients with locally advanced prostate cancer | Bertrand Tombal (Belgium) |
15:50-16:10 | Locally advanced Prostate Cancer: Navigating Controversies in Radiation and Surgical Strategies | Fumihiko URABE (Japan) |
16:10-16:30 | Medical treatment in high-risk localised or locally advanced prostate cancer | Amit BAHL (UK) |
16:30-16:50 | Managing prostate cancer patients with PSA persistence after RP | Takahiro INOUE (Japan) |
16:50-17:30 | Case Discussion | Moderator: Seong Hyeon YU (Korea) |
Soodong KIM (Korea) | ||
Hongzoo PARK (Korea) | ||
Jae Hyun RYU (Korea) | ||
Kuan Chou CHEN (Taiwan) | ||
Joseph KIM (USA) | ||
17:30 | Welcome Dinner |
Moderator: Jong Wook KIM (Korea)
Time | Program | Chair / Speaker |
---|---|---|
09:10-10:00 | Session III: Prostate Cancer III (Surgery & Focal Therapy): Precision and Innovation | Moon Ki JO (Korea) |
Kyung Hyun MOON (Korea) | ||
09:10-09:17 | Sparing the periprostatic neurovascular bundles during robot-assisted radical prostatectomy (RARP) | Dalsan YOU (Korea) |
09:17-09:24 | Next generation robot-assisted surgery (RAS) platform | See Min CHOI (Korea) |
09:24-09:31 | New options of prostate focal therapy | Hakmin LEE (Korea) |
09:31-09:38 | Cytoreductive Prostatectomy in the management of men with oligometastatic prostate cancer | Hee Jo YANG (Korea) |
09:38-10:00 | Case Discussion | Moderator: Hyung Joon KIM (Korea) |
Hoon CHOI (Korea) | ||
In Chang CHO (Korea) | ||
Lukman HAKIM (Indonesia) | ||
Takashi FUKAGAI (Japan) | ||
10:00-10:40 | Satellite Symposium sponsored by Duchem Bio | Jongwook PARK (Korea) |
10:00-10:20 | Advancing Precision in Prostate Cancer Imaging with PSMA PET: Clinical Evidence of 18F-PSMA-7.3 (Prostaseek) | Minseok SUH (Korea) |
10:20-10:40 | Commemorative Photo & Coffee Break/Visit Exhibits | |
10:40-11:50 | Session IV: Urothelial Cancer: From Biomarkers to Clinical Decision Making | Ho Kyung SEO (Korea) |
Jae Seung CHUNG (Korea) | ||
Kuan Chou CHEN (Taiwan) | ||
10:40-11:00 | High grade non muscle invasive urothelial carcinoma - what's the next step? | Ilker TINAY (Türkiye) |
11:00-11:07 | MIBC Treatment Decisions: Role of ctDNA, utDNA, and Timing of Radical Cystectomy | Kyung Hwan KIM (Korea) |
11:07-11:14 | Post-NAC cT0: Still Indication for Radical Cystectomy | Geehyun SONG (Korea) |
11:14-11:21 | Bladder Cancer After UTUC: Contemporary Insights into Risk Factors and Prevention | Jong Kil NAM (Korea) |
11:21-11:50 | Case Discussion | Moderator: Joongwon CHOI (Korea) |
Byung Hoon KIM (Korea) | ||
Jung Ki JO (Korea) | ||
11:50-12:05 | KPS BLUE Award | Jae-Young JOUNG (Korea) |
12:05-13:05 | Luncheon Symposium sponsored by Janssen | Jae Young PARK (Korea) |
12:05-12:25 | Evidenced-based Use of AR Pathway inhibitor for Advanced prostate cancer | Joseph KIM (USA) |
12:25-13:05 | Lunch | |
13:05-14:45 | Session V: Prostate Cancer IV (mHSPC): Biomarkers, Intensification, and De-escalation Debate | Jae Il CHUNG (Korea) |
Hwang Gyun JEON (Korea) | ||
Bannakij LOJANAPIWAT (Thailand) | ||
13:05-13:12 | Importance of early genetic testing in metastatic prostate cancer | Yong Hyun PARK (Korea) |
13:12-13:32 | Treatment optimisation in mHSPC | Amit BAHL (UK) |
13:32-13:52 | Drug Treatment Strategies in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): Current Evidence and Future Perspectives | Fumihiko URABE (Japan) |
13:52-14:17 | mHSPC with deep response to ADT plus ARPI | |
13:52-14:02 | 1, Contra de-escalation | Yun Sok HA (Korea) |
14:02-14:17 | 2, Pro de-escalation | Takahiro KIMURA (Japan) |
14:17-14:45 | Case Discussion | Moderator: Sang Hun SONG (Korea) |
Jongwook PARK (Korea) | ||
Ho Young BAE (Korea) | ||
14:45-15:25 | Satellite Symposium sponsored by Astellas | Tag Keun YOO (Korea) |
14:45-15:05 | My Practice with Harnal & Betmiga | Jae Heon KIM (Korea) |
15:05-15:25 | Coffee Break / Visit Exhibits | |
15:25-17:05 | Session VI: Prostate Cancer V (mCRPC): Sequencing, Theranostics, and the Future | Taek Won KANG (Korea) |
U-Syn HA (Korea) | ||
Lukman HAKIM (Indonesia) | ||
15:25-15:45 | Modern Sequencing and Intensification Strategies in mCRPC: From Guidelines to Genomics | Bertrand TOMBAL (Belgium) |
15:45-15:52 | Navigating therapeutic sequencing in mCRPC: PARPi and systemic therapy | Bum Sik TAE (Korea) |
15:52-16:12 | Advancing the utilization of PET imaging for staging and PSMA Theranostics: Role of PSMA and FDG PET Radiomics to Predict Treatment Response | Frédéric POULIOT (Canada) |
16:12-16:32 | PSMA targeted α-radiation therapy: Recent advances and future perspectives | Yoshiyuki KOJIMA (Japan) |
16:32-17:05 | Case discussion | Moderator: Se Young CHOI (Korea) |
Seyun KWON (Korea) | ||
Sangchul LEE (Korea) | ||
Taeyoung PARK (Korea) | ||
Eugene TEOH (UK) | ||
17:05-17:15 | Best Abstract Prize | Jae-Young JOUNG (Korea) |
17:15-17:25 | Closing Remarks | Jae Young JOUNG (Korea) |
17:25 | Banquet |
Copyright(C) by 2025 KPS in conjunction with APSU Joint International Symposium.
All rights reserved.
Secretariat of KPS
Gaon Convention Services, Inc.
ADDRESS: ROOM 1005, 228, Gonghang-daero, Gangseo-gu, Seoul, Republic of Korea.
TEL : +82-2-6956-7989 | E-MAIL : gaonpco@gaonpco.com
* 의사 회원인 경우에는 연수평점 카드 기록을 위해서 필요 합니다.